Luxempart, a private equity firm listed on the Luxembourg bourse, said on Thursday that it has generated a “significant” investment return by selling the bulk of its stake in Swiss diagnostic radiology firm Rimed to diagnostic services provider Unilabs.
Register or log in to continue reading. Investment Officer is an independent journalism platform for professionals working in the Luxembourg investment industry.
A subscription is free for professionals working at banks and independent asset managers.
